|1|Time trends and inter-hospital variation in treatment and axillary staging of patients with ductal carcinoma in situ of the breast in the era of screening in Southern Netherlands. (24291376)
van Steenbergen L.N.... van de Poll-Franse L.V.
|2|Synchronous ductal carcinoma in situ of the breast and within epithelial inclusions in an ipsilateral sentinel lymph node. (23089490)
Fitzpatrick-Swallow V.L.... Pinder S.E.
|3|Combined inhibition of ErbB1/2 and Notch receptors effectively targets breast ductal carcinoma in situ (DCIS) stem/progenitor cell activity regardless of ErbB2 status. (23457626)
Farnie G.... Bundred N.J.
|4|Role of HGF in epithelial-stromal cell interactions during progression from benign breast disease to ductal carcinoma in situ. (24025166)
Casbas-Hernandez P.... Troester M.A.
|5|EZH2 and ALDH1 expression in ductal carcinoma in situ: complex association with recurrence and progression to invasive breast cancer. (23759596)
Knudsen E.S.... Witkiewicz A.K.
|6|Extensive pure ductal carcinoma in situ of the breast: Identification of predictors of associated infiltrating carcinoma and lymph node metastasis before immediate reconstructive surgery. (24388733)
Guillot E.... Reyal F.
|7|Paired ductal carcinoma in situ and invasive breast cancer lesions in the D-loop of the mitochondrial genome indicate a cancerization field effect. (23509716)
Maggrah A.... Parr R.
|8|Quality indicators for ductal carcinoma in situ (DCIS) of the breast: development using a multidisciplinary delphi process and its use in monitoring population-based treatment. (24038038)
Chin-Lenn L.... Quan M.L.
|9|Neuroendocrine ductal carcinoma in situ, comedo type, of the breast detected by screening mammography: a potentially pre-invasive counterpart of high grade neuroendocrine tumours. (22437750)
Kawasaki T.... Katoh R.
|10|Combined evaluation of CK5/6, ER, p63, and MUC3 for distinguishing breast intraductal papilloma from ductal carcinoma in situ. (22612506)
FURUYA C.... Takahashi M.
|11|The role of breast MR imaging in pre-operative determination of invasive disease for ductal carcinoma in situ diagnosed by needle biopsy. (22205445)
Goto M.... Yamada K.
|12|Differentially expressed genes regulating the progression of ductal carcinoma in situ to invasive breast cancer. (22751464)
Lee S.... Allred D.C.
|13|Conservative treatment of breast ductal carcinoma in situ: results of an Italian multi-institutional retrospective study. (23098066)
Vidali C.... Pietta N.
|14|Ductal carcinoma in situ that involves sclerosing adenosis: high frequency of bilateral breast cancer occurrence. (23083502)
Yoshida A.... Tsunoda H.
|15|Asymptomatic Incidental Ductal Carcinoma in situ in a Male Breast Presenting with Contralateral Gynecomastia. (22530182)
Isley L.M.... Bernard J.M.
|16|Serum autoantibody signature of ductal carcinoma in situ progression to invasive breast cancer. (22322670)
MangAc A.... Solassol J.
|17|Incidence and possible pathogenesis of sentinel node micrometastases in ductal carcinoma in situ of the breast detected using molecular whole lymph node assay. (22531630)
Osako T.... Akiyama F.
|18|Intraoperative assessment of surgical margins during breast conserving surgery of ductal carcinoma in situ by use of radiofrequency spectroscopy. (21885281)
Thill M.... Dittmer C.
|19|Is CD56 a specific and reliable neuroendocrine marker for discriminating between endocrine/neuroendocrine ductal carcinoma in situ and intraductal papilloma of the breast? (21166944)
Kawasaki T.... Katoh R.
|20|Increased breast density correlates with the proliferation-seeking radiotracer (99m)Tc(V)-DMSA uptake in florid epithelial hyperplasia and in mixed ductal carcinoma in situ with invasive ductal carcinoma but not in pure invasive ductal carcinoma or in mild epithelial hyperplasia. (21521552)
Papantoniou V.... Antsaklis A.
|21|Ductal carcinoma in situ of the breast: influence of age on diagnostic, therapeutic, and prognostic features. Retrospective study of 812 patients. (21108045)
Tunon-de-Lara C.... Avril A.
|22|Indication for sentinel lymph node biopsy for breast cancer when core biopsy shows ductal carcinoma in situ. (21741518)
Miyake T.... Noguchi S.
|23|Different distribution of breast cancer subtypes in breast ductal carcinoma in situ (DCIS), DCIS with microinvasion, and DCIS with invasion component. (21042943)
Yu K.D.... Shao Z.M.
|24|Inclusion of tumor biology molecular markers to improve the ductal carcinoma in situ ipsilateral breast tumor recurrence nomogram predictability. (21172894)
Ballehaninna U.K.... Chamberlain R.S.
|25|Molecular diversity in ductal carcinoma in situ (DCIS) and early invasive breast cancer. (20663721)
Muggerud A.A.... WAornberg F.
|26|Molecular differences between ductal carcinoma in situ and adjacent invasive breast carcinoma: a multiplex ligation-dependent probe amplification study. (20978320)
Moelans C.B.... van Diest P.J.
|27|Estrogen receptor, progesterone receptor, and glucocorticoid receptor expression in normal breast tissue, breast in situ carcinoma, and invasive breast cancer. (19875955)
Buxant F.... NoAl J.C.
|28|Costimulatory molecule OX40/OX40L expression in ductal carcinoma in situ and invasive ductal carcinoma of breast: an immunohistochemistry-based pilot study. (20634005)
Xie F.... Zhang X.
|29|Pregnancy-related factors and the risk of breast carcinoma in situ and invasive breast cancer among postmenopausal women in the California Teachers Study cohort. (20565829)
Ma H.... Bernstein L.
|30|Intracrinology of sex steroids in ductal carcinoma in situ (DCIS) of human breast: comparison to invasive ductal carcinoma (IDC) and non-neoplastic breast. (19444935)
Miki Y.... Sasano H.
|31|D2-40 expression by breast myoepithelium: potential pitfalls in distinguishing intralymphatic carcinoma from in situ carcinoma. (18206495)
Rabban J.T.... Chen Y.Y.
|32|Intratumoral concentration of sex steroids and expression of sex steroid-producing enzymes in ductal carcinoma in situ of human breast. (18310280)
Shibuya R.... Sasano H.
|33|OSM, LIF, its receptors, and its relationship with the malignance in human breast carcinoma (in situ and in infiltrative). (18317962)
GarcA-a-TuA+A^n I.... Royuela M.
|34|P63 and cytokeratin8/18 expression in breast, atypical ductal hyperplasia, ductal carcinoma in situ and invasive duct carcinoma. (19190693)
Shamloula M.M.... Saied E.M.
|35|Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast. (17522367)
Steinman S.... Tang P.
|36|Expression of androgen receptor and two androgen-induced proteins (apolipoprotein D and pepsinogen C) in ductal carcinoma in situ of the breast. (17543076)
Gonzalez L.O.... Vizoso F.J.
|37|Synchronous bilateral ductal carcinoma in situ of the male breast associated with gynecomastia in a 30-year-old patient following repeated injections of stanozolol. (16328719)
Staerkle R.F.... Melcher A.
|38|Expression of sialyl lewis X, sialyl Lewis A, E-cadherin and cathepsin-D in human breast cancer: immunohistochemical analysis in mammary carcinoma in situ, invasive carcinomas and their lymph node metastasis. (16033070)
Jeschke U.... Friese K.
|39|Loss of heterozygosity at BRCA2 in a ductal carcinoma in situ and three invasive breast carcinomas in a family with a germline BRCA2 mutation. (15528970)
Thomassen M.... Gerdes A.M.
|40|Loss of aurora A/STK15/BTAK overexpression correlates with transition of in situ to invasive ductal carcinoma of the breast. (14693746)
Hoque A.... Lippman S.M.
|41|Invasive ductal carcinoma of the breast: study of the number of copies of the CCND1 gene and chromosome 11 using fluorescence in situ hybridization (FISH) in comparison with expression of cyclin D1 protein and estrogen receptors (ER alpha) with immunohistochemical detection]. (12532908)
MrhalovA! M.... Strnad P.
|42|Incidence of second cancers among women with in situ carcinoma of the breast. (14965621)
Crocetti E.... Zappa M.
|43|Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas. (11585740)
Nielsen B.S.... LA^pez-OtA-n C.
|44|Down-regulation of gelsolin expression in human breast ductal carcinoma in situ with and without invasion. (10481945)
Asch H.L.... Asch B.B.
|45|Genetic alterations in early-onset invasive breast carcinomas: correlation of c-erbB-2 amplification detected by fluorescence in situ hybridization with p53 accumulation and tumor phenotype. (10502729)
Fiche M.... Maugard C.M.
|46|Simultaneous loss of E-cadherin and catenins in invasive lobular breast cancer and lobular carcinoma in situ. (9496256)
de Leeuw W.J.... Cleton-Jansen A.M.
|47|Fluorescence in situ hybridization assessment of chromosome 8 copy number in stage I and stage II infiltrating ductal carcinoma of the breast. (9283590)
Afify A.... Mark H.F.
|48|Prognostic significance of in situ carcinoma associated with invasive breast carcinoma: a natural experiment in cancer immunology? (9129007)
Naresh K.N.... Borges A.M.
|49|Quantitative study of ductal breast cancer progression. A progression index (P.I.) for premalignant lesions and in situ carcinoma. (8832747)
Mariuzzi G.M.... Bartels P.H.
|50|Transforming growth factor beta 1 in ductal carcinoma in situ and invasive carcinomas of the breast. (1317202)
Walker R.A.... Dearing S.J.